Min-Ju Kim

@orcid.org

Pharmacy
Pusan National university

104

Scholar Citations

4

Scholar h-index

2

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

  • Integrative transcriptomic analysis identifies emetine as a promising candidate for overcoming acquired resistance to ALK inhibitors in lung cancer
    SM Park, K Haam, H Heo, D Kim, MJ Kim, HJ Jung, S Cha, M Kim, H Lee
    Molecular Oncology 19 (4), 1155-1169 , 2025
    2025
    Citations: 3
  • Tonic type 2 immunity is a critical tissue checkpoint controlling autoimmunity in the skin
    JE Lee, M Kim, S Ochiai, SH Kim, H Yeo, J Bok, J Kim, M Park, D Kim, ...
    Cell Reports 43 (7) , 2024
    2024
    Citations: 9
  • SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activity
    JA Kang, YJ Kim, KY Jang, HW Moon, H Lee, S Lee, HK Song, SW Cho, ...
    Experimental & molecular medicine 56 (3), 656-673 , 2024
    2024
    Citations: 15
  • Amelioration of astrocyte-mediated neuroinflammation by EI-16004 confers neuroprotection in an MPTP-induced Parkinson’s disease model
    J Kim, S Lee, DG Hong, S Yang, CS Tran, J Kwak, MJ Kim, ...
    NeuroMolecular Medicine 26 (1), 1 , 2024
    2024
    Citations: 4
  • FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and-independent manner
    JW Kim, MJ Kim, TH Han, JY Lee, S Kim, H Kim, KJ Oh, WK Kim, BS Han, ...
    Cell Death & Disease 14 (8), 567 , 2023
    2023
    Citations: 64
  • FSP1 and NRF2 independently contribute to ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma
    KIM JongWoo, MJ Kim, TH Han, JY Lee, S Kim, H Kim, KJ Oh, WK Kim, ...
    2023
  • Epigenetic activation of tensin 4 promotes gastric cancer progression
    H Heo, HJ Kim, K Haam, HA Sohn, YJ Shin, H Go, HJ Jung, JH Kim, ...
    Molecules and cells 46 (5), 298-308 , 2023
    2023
    Citations: 9

MOST CITED SCHOLAR PUBLICATIONS

  • FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and-independent manner
    JW Kim, MJ Kim, TH Han, JY Lee, S Kim, H Kim, KJ Oh, WK Kim, BS Han, ...
    Cell Death & Disease 14 (8), 567 , 2023
    2023
    Citations: 64
  • SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activity
    JA Kang, YJ Kim, KY Jang, HW Moon, H Lee, S Lee, HK Song, SW Cho, ...
    Experimental & molecular medicine 56 (3), 656-673 , 2024
    2024
    Citations: 15
  • Tonic type 2 immunity is a critical tissue checkpoint controlling autoimmunity in the skin
    JE Lee, M Kim, S Ochiai, SH Kim, H Yeo, J Bok, J Kim, M Park, D Kim, ...
    Cell Reports 43 (7) , 2024
    2024
    Citations: 9
  • Epigenetic activation of tensin 4 promotes gastric cancer progression
    H Heo, HJ Kim, K Haam, HA Sohn, YJ Shin, H Go, HJ Jung, JH Kim, ...
    Molecules and cells 46 (5), 298-308 , 2023
    2023
    Citations: 9
  • Amelioration of astrocyte-mediated neuroinflammation by EI-16004 confers neuroprotection in an MPTP-induced Parkinson’s disease model
    J Kim, S Lee, DG Hong, S Yang, CS Tran, J Kwak, MJ Kim, ...
    NeuroMolecular Medicine 26 (1), 1 , 2024
    2024
    Citations: 4
  • Integrative transcriptomic analysis identifies emetine as a promising candidate for overcoming acquired resistance to ALK inhibitors in lung cancer
    SM Park, K Haam, H Heo, D Kim, MJ Kim, HJ Jung, S Cha, M Kim, H Lee
    Molecular Oncology 19 (4), 1155-1169 , 2025
    2025
    Citations: 3
  • FSP1 and NRF2 independently contribute to ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma
    KIM JongWoo, MJ Kim, TH Han, JY Lee, S Kim, H Kim, KJ Oh, WK Kim, ...
    2023